Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.65 trillion as of March 9, 2026. Its market cap has increased by 23.72% in one year.

Market Cap

2.65T

Enterprise Value

2.64T

Revenue

154.05B

Ranking

n/a

PE Ratio

1,147.33

Stock Price

52,200.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.65T, an increase of 9,979.00%. That is a compound annual growth rate of 16.30%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	2,650.71B	19.31%
Dec 30, 2025	2,221.62B	13.35%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion Pharm	2,718.50B
Daewoong Pharmaceutical	1,865.17B
GC Biopharma	1,645.78B
Hanmi Pharm.	6,105.52B
Chong Kun Dang Pharmaceutical	1,093.61B
Yuhan	7,163.24B
Ildong Pharmaceutical	972.02B
Daewoong	903.68B

Market Cap Rankings